Conquering Diseases

Newly Diagnosed Acute Myeloid Leukemia (AML) Study

Description

Seeking men & women over 18 years old who have recently been diagnosed with acute myeloid leukemia (AML) but are not medically suitable to receive standard chemotherapy.

Overview

The main purpose of this study is to investigate the effects the investigational drug has on the patient and their cancer when it is given in combination with another standard drug.

What we're hoping for

Participation in this study may help researchers in gaining knowledge to help other patients with AML in the future.

Additional Information

ClinicalTrials.gov Identifier: NCT03151408

 Principal Investigator

Jan  Cerny, MD, PhD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989